Alexander Rau

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Tyrosine Kinase

Top Venues

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Alexander Rau, Nicole Janssen, Lennart Kühl, Thomas Sell, Svetlana Kalmykova, Thomas E Mürdter, Marc-H Dahlke, Christine Sers, Markus Morkel, Matthias Schwab, Roland E Kontermann, Monilola A Olayioye
Triple Targeting of HER Receptors Overcomes Heregulin-mediated Resistance to EGFR Blockade in Colorectal Cancer. Molecular cancer therapeutics 21 (5) (2022)
Alexander Rau, Katharina Kocher, Mirjam Rommel, Lennart Kühl, Maximilian Albrecht, Hannes Gotthard, Nadine Beha, Bettina Noll, Monilola A Olayioye, Roland E Kontermann, Oliver Seifert
A bivalent, bispecific Dab-Fc antibody molecule for dual targeting of HER2 and HER3. mAbs 13 (1) (2022)
Alexander Rau, Wolfgang S Lieb, Oliver Seifert, Jonas Honer, Dennis Birnstock, Fabian Richter, Nadine Aschmoneit, Monilola A Olayioye, Roland E Kontermann
Inhibition of Tumor Cell Growth and Cancer Stem Cell Expansion by a Bispecific Antibody Targeting EGFR and HER3. Molecular cancer therapeutics 19 (7) (2020)
Oliver Seifert, Alexander Rau, Nadine Beha, Fabian Richter, Roland E Kontermann
Diabody-Ig: a novel platform for the generation of multivalent and multispecific antibody molecules. mAbs 11 (5) (2019)